FREE SHIPPING ON ORDERS OVER $100

Research Categories
Research Categories

Research

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Peptides BPC157, AOD9604, MOTS-c improve Bone Mineral Density for Osteoporosis.

Osteoporosis is the most prevalent systemic skeletal system disease, leading to increased bone fragility and vulnerability to fractures. Due to the microarchitectural destruction in bone tissue, fracture healing in osteoporoti patients is often delayed and compromised compared with non‑osteoporotic individuals. Osteoporosis usually results from meno‑ pause, aging, metabolic diseases and drug therapies with the precise cellular and molecular mechanism remaining to be elucidated.

Recent studies have shown that four peptides (BPC-157AOD 9604MOTS-c, Peptide 11R‐VIVIT) have been proven to have healing effects for such disease in several types of model… High concentration and long-term stimulation of TGF-β1 induced osteogenic differentiation of bone marrow mesenchymal stem cells (MSCs) in vitr2. TGF-β pathway-related genes exert anti-osteoporosis effects by regulating the function of bone deposits and osteoclasts. TGF-β also affects the bone formation by promoting the proliferation and differentiation of osteoblasts, as well as the synthesis of extracellular matrix.

Cagrilintide Research: What is Cagrilintide? How does it work?

The Obesity Epidemic

Obesity has become one of the most pressing public health challenges in the United States and around the world. In the U.S., about 42% of adults are classified as obese, a figure that has nearly tripled over the past 50 years. Globally, over 650 million people are classified as obese, and this number continues to rise rapidly. Obesity increases the risk for many serious health conditions, including heart disease, type 2 diabetes, stroke, and certain cancers, making it a major contributor to premature death and disability worldwide.

Obesity is difficult to control due to several complex factors. It’s not simply a matter of overeating or lack of exercise; rather, it stems from a mix of genetics, hormonal imbalances, metabolism, and environmental factors, such as the easy availability of high-calorie foods and increasingly sedentary lifestyles. This complexity makes it challenging to address basic “eat less, move more” strategies. Additionally, many individuals struggle with yo-yo dieting, where initial weight loss is followed by weight regain once normal eating patterns resume. This cycle makes maintaining weight loss over the long term even more difficult. Furthermore, the medications currently available for weight loss often have limited effectiveness and can come with side effects, making them less appealing for long-term use. Most of these drugs only target specific aspects of obesity, like appetite suppression or metabolism, which doesn’t fully address the root causes of the issue.

How can Thymosin Beta4 (TB500) improve recovery, inflammation, neuropathies, fibrosis, telomerase and senescent cell removal?

Thymosin B4 Reduces Inflammation by Upregulating MicroRNA-146a and Promotes Myelin

“Tissue inflammation results from neurological injury, and regulation of the inflammatory response is vital for neurological recovery. The innate immune response system, which includes the Toll-like receptor (TLR) proinflammatory signaling pathway, regulates tissue injury… TB4-mediated oligodendrogenesis results from [up-regulating] miR-146a [causing the] suppression [of] the TLR proinflammatory pathway and modulation of the p38 MAPK pathway.” (8)“By targeting IRAK1 and TRAF6, miR-146 inhibits NF-κB activation. We therefore hypothesized that TB4 regulates the TLR proinflammatory signaling pathway by specifically regulating miR-146a to promote differentiation of OPCs [oligodendrocyte progenitor cells] to mature myelin basic protein (MBP)-expressing OLs [oligodendrocytes]… transfection with anti-miR-146a inhibitor nucleotides significantly inhibited the expression of MBP and phosphorylation of p38 MAPK.” (8)

Thymosin Beta 4 and Cardiac Regeneration

Thymosin β4 and Prothymosin α Promote Cardiac Regeneration Post-Ischaemic Injury in Mice

“The adult mammalian heart is a post-mitotic organ. Even in response to necrotic injuries, where regeneration would be essential to reinstate cardiac structure and function, only a minor percentage of cardiomyocytes undergo cytokinesis… In this study, we aimed to determine the gene expression profile of proliferating adult cardiomyocytes in the mammalian heart after myocardial ischaemia, to identify factors to can promote cardiac regeneration… Here, we demonstrate increased 5-ethynyl-2’deoxyuridine incorporation in cardiomyocytes 3 days post-myocardial infarction in mice… Combinatorial overexpression of the enriched genes within this population in neonatal rat cardiomyocytes and mice at postnatal day 12 (P12) unveiled key genes that promoted increased cardiomyocyte proliferation. Therapeutic delivery of these gene cocktails into the myocardial wall after ischaemic injury demonstrated that a combination of thymosin beta 4 (TMSB4) and prothymosin alpha (PTMA) provide a permissive environment for cardiomyocyte proliferation and thereby attenuated cardiac dysfunction… This study reveals the transcriptional profile of proliferating cardiomyocytes in the ischaemic heart and shows that overexpression of the two identified factors, TMSB4 and PTMA, can promote cardiac regeneration.” (2)

The Role of Thymosin β4 in Cardiomyocyte Proliferation and Cardiac Regeneration

“Thymosin β4 (Tβ4) is a 43-amino acid protein that belongs to the β-thymosin family, which is highly conserved… Tβ4 has been associated with wound healing, inflammation, fibrosis, and tissue regeneration, with recent studies suggesting that Tβ4 can help prevent inflammation and fibrosis in the eye, skin, lung, and liver… Tβ4 is a potent protective factor that can protect against myocyte damage, promote myocyte regeneration, and inhibit heart inflammation… Therefore, we propose that Tβ4 might have an antifibrotic function in the heart.” (3)

TB-500 (Thymosin Beta-4) Peptide Research

TB-500 also known as Thymosin Beta 4 is a naturally occurring peptide. It is found in high concentrations in blood platelets, wound fluid and other tissues in the body. TB-500 is not a growth factor; rather, it is a major actin regulating peptide. TB-500 (Thymosin Beta 4) has been found to play an important role in protection, regeneration and remodeling of injured or damaged tissues. The gene for TB-500 (Thymosin Beta 4) has also been found to be one of the first to be upregulated after a wound occurs.

Welcome back!

or
Menu
Explore

Search Peptides

Welcome back!

or
0